Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benign Migratory Glossitis Associated With Antiangiogenic Drugs Used in Cancer Treatment

NCT06988865 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.

NCT NCT06988865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06988865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benign Migratory Glossitis Associated With Antiangiogenic Drugs Used in Cancer Treatment
Lead sponsor
Instituto do Cancer do Estado de São Paulo
Phase
Observational
Overall status
Completed
Start date
July 16, 2017
Completion date
February 1, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, geographic tongue